---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-084064"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2026-07-31T20:56:20+00:00"
generated_at: "2026-07-31T20:57:05.923783+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Profusa signs option to acquire G3 Vision Labs; G3 had ~$111M 2025 revenue

## Summary
- Option to acquire G3 Vision Labs and its subsidiaries (Med Screen, Dominion, Acutis) for equity consideration.
- G3's unaudited 2025 net revenues ~$111M; combined entity would be a public diagnostics company.
- Conditions: Profusa must raise at least $30M in financing, obtain stockholder approval, refinance G3 debt.
- As option consideration, Profusa issued 201,120 common shares and 52,904 Series A Preferred shares (convertible to common 1:1000).
- Company believes it now meets Nasdaq minimum stockholders' equity of $2.5M for continued listing.

## SEC filing metadata
- accession: 0001213900-26-084064
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2026-07-31T20:56:20+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390026084064/0001213900-26-084064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390026084064/ea0300017-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-084064
- JSON: https://secwatch.observer/filing/0001213900-26-084064.json
- Plain text: https://secwatch.observer/filing/0001213900-26-084064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.